Detalhe da pesquisa
1.
A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
Oncologist
; 26(10): 811-817, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018286
2.
Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of Genomics.
Oncologist
; 26(12): 1000-1005, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423517
3.
Xenogeneic fibroblasts inhibit the growth of the breast and ovarian cancer cell lines in co-culture.
Neoplasma
; 68(6): 1265-1271, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34734528
4.
Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion.
J Natl Compr Canc Netw
; 18(3): 223-228, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135515
5.
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
Hered Cancer Clin Pract
; 17: 21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346352
6.
Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutation.
J Natl Compr Canc Netw
; 16(5): 461-466, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752319
7.
Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
Breast Cancer Res Treat
; 166(1): 315-319, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28702897
8.
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
Cardiooncology
; 10(1): 3, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225669
9.
Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.
J Am Coll Radiol
; 20(1): 71-78, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516954
10.
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.
J Transl Med
; 10: 79, 2012 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22541066
11.
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.
Gynecol Oncol
; 121(3): 455-61, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21414654
12.
Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
JAMA
; 316(1): 93-4, 2016 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380347
13.
Hypofractionated radiation in secretory breast cancer: A case report.
Rare Tumors
; 13: 20363613211045252, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34603639
14.
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing.
J Ovarian Res
; 14(1): 61, 2021 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926482
15.
Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center.
Cancer Rep (Hoboken)
; 3(6): e1287, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881420
16.
Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination.
Adv Radiat Oncol
; 4(3): 453-457, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31360799
17.
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicintreated breast cancer patients: a prospective exploratory study.
Cardiooncology
; 10(1): 5, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321512
18.
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
PLoS One
; 13(4): e0195497, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659587
19.
Hereditary inflammatory breast cancer associated with BRCA2 mutation: a rare disease presentation in mother and daughter.
Clin Adv Hematol Oncol
; 10(6): 402-4, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895246
20.
Anastrozole-induced Autoimmune Hepatitis: A Rare Complication of Breast Cancer Therapy.
Anticancer Res
; 37(8): 4173-4176, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28739702